Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
50,000
Employees50,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
50,000
Employees50,000

LLY Key Statistics

Market cap
1.08T
Market cap1.08T
Price-Earnings ratio
41.35
Price-Earnings ratio41.35
Dividend yield
0.56%
Dividend yield0.56%
Average volume
2.22M
Average volume2.22M
High today
$1,159.00
High today$1,159.00
Low today
$1,119.00
Low today$1,119.00
Open price
$1,145.74
Open price$1,145.74
Volume
2.88M
Volume2.88M
52 Week high
$1,249.45
52 Week high$1,249.45
52 Week low
$623.78
52 Week low$623.78

Stock Snapshot

Eli Lilly(LLY) stock is priced at $1,149.00, giving the company a market capitalization of 1.08T. It carries a P/E multiple of 41.35 and pays a dividend yield of 0.56%.

On 2026-08-02, Eli Lilly(LLY) stock traded between a low of $1,119.00 and a high of $1,159.00. Shares are currently priced at $1,149.00, which is +2.7% above the low and -0.9% below the high.

The Eli Lilly(LLY)'s current trading volume is 2.88M, compared to an average daily volume of 2.22M.

During the past year, Eli Lilly(LLY) stock moved between $623.78 at its lowest and $1,249.45 at its peak.

During the past year, Eli Lilly(LLY) stock moved between $623.78 at its lowest and $1,249.45 at its peak.

LLY News

Barron's 54m
Jobs Report, Palantir, AMD, SpaceX, Eli Lilly, and More to Watch This Week

Markets Jobs Report, Palantir, AMD, SpaceX, Eli Lilly, and More to Watch This Week In this article SPX PLTR AMD SPCX LLY Equities rebounded from a midweek slump...

Jobs Report, Palantir, AMD, SpaceX, Eli Lilly, and More to Watch This Week
Simply Wall St 5h
Eli Lilly Stock Looks Cheap Even As Broader Checks Stay Mixed

Eli Lilly stock has delivered a very large 5 year return, yet the current valuation picture is not straightforward. The intrinsic value estimate based on a Disc...

Eli Lilly Stock Looks Cheap Even As Broader Checks Stay Mixed
Nasdaq 7h
Abbott Laboratories vs. Eli Lilly: Which Healthcare Stock Is a Better Buy in 2026?

Key Points Abbott Laboratories maintains a diversified business model spanning diagnostics, medical devices, and nutrition products. Eli Lilly is experiencing...

Abbott Laboratories vs. Eli Lilly: Which Healthcare Stock Is a Better Buy in 2026?

Analyst ratings

81%

of 31 ratings
Buy
80.6%
Hold
12.9%
Sell
6.5%

More LLY News

Nasdaq 22h
Prediction: Eli Lilly Will Be Worth $2 Trillion by 2031

Key Points Expanding the GLP-1 market with new launches and label expansions will help Eli Lilly overcome increased competition. The company should also devel...

Prediction: Eli Lilly Will Be Worth $2 Trillion by 2031
Investor's Business Daily 1d
A SpaceX Earnings Preview: Starlink Growth, AI Costs, Starship Roadmap

Dow Jones Futures: Market Rebounds, Now Watch For This; SpaceX, AMD, Sandisk, Eli Lilly Earnings Loom 7/31/2026 The stock market bounced but hasn't taken this...

A SpaceX Earnings Preview: Starlink Growth, AI Costs, Starship Roadmap
Nasdaq 2d
Eli Lilly Stock Has Skyrocketed. Novo Nordisk Has Crashed. 1 Number Explains Why They're Not Even Close Anymore.

Key Points Both companies are giants in diabetes and obesity treatments. Lately, Eli Lilly has moved ahead in the obesity segment. Things could change, howev...

Eli Lilly Stock Has Skyrocketed. Novo Nordisk Has Crashed. 1 Number Explains Why They're Not Even Close Anymore.
24/7 Wall St. 2d
Novo Nordisk vs Eli Lilly: The Better Buy Before Earnings

Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Eli Lilly didn't make the cut. Grab the names FREE today . Novo pre-announ...

Novo Nordisk vs Eli Lilly: The Better Buy Before Earnings
TipRanks 3d
Lilly’s Retatrutide Trial Reaches Completion, Setting Up Next Catalyst in Obesity and Heart Disease

Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more co...

TipRanks 3d
Eli Lilly Is Investing Another $750 Million in Its U.S. Manufacturing Facilities

Eli Lilly’s (LLY) stock is down 4% on July 30 after the pharmaceutical giant announced plans to invest another $750 million to expand its U.S. manufacturing cap...

Nasdaq 4d
Watch Out, Eli Lilly and Novo Nordisk: Amgen's Monthly Weight Loss Drug Has 6 Phase 3 Trials Running -- and It's Coming for Your Patients

Key Points Amgen wants a slice of the weight loss drug market. Its candidate for capturing that market share might not be up to the task. Its competitors are...

Watch Out, Eli Lilly and Novo Nordisk: Amgen's Monthly Weight Loss Drug Has 6 Phase 3 Trials Running -- and It's Coming for Your Patients

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.